ABIONYX PHARMA: cash_and_equivalents
| Value | {"amount": 7935000.0, "concept": "ifrs-full:CashAndCashEquivalents"} |
|---|---|
| Period | (as of 2021-12-31) |
| Status | current |
| Entity | ABIONYX PHARMA |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-24T00:57:07.391012+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/ebf3ec3c-e881-4f22-ac01-3cb54ecf66a8
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:969500785J7VIC5YPC96:2022-12-31Retrieved: 2026-08-24T00:57:07.391012+02:00
Raw response sha256:
6a2b623de4454d15f9b99020bed4c4d5…Cite as: FACTANKER, https://factanker.com/fact/ebf3ec3c-e881-4f22-ac01-3cb54ecf66a8
History
- no predecessors — first report